CTOR earnings: next report 2026-08-18, real EPS beat/miss history, analyst consensus Buy, P/E -1.22. Updated 2026-07-23.
Citius Oncology (CTOR) Research Hub
Citius Oncology (CTOR) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-09-11, shares last closed at 0.9175 USD (-2.39%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.22, market cap 0.06B. This hub links to the full technical, earnings and options research available for CTOR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9175 USD (-2.39%) |
| 52-week range | 0.5188 USD – 0.96 USD |
| Trend regime | Range |
| 14-day RSI | 64.5 (Bullish) |
| Trailing P/E | -1.22 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-18 |
Available research for CTOR
Covered Call on CTOR: how it works, illustrative setup around the real 0.9175 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CTOR: how it works, illustrative setup around the real 0.9175 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CTOR: how it works, illustrative setup around the real 0.9175 USD price, max profit/loss, breakeven and when to use it. Educational.
CTOR technical analysis: range, last 0.9175 USD, RSI 64.5, 52w range 0.5188 USD–0.96 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CTOR in?
Citius Oncology (CTOR) is classified under Healthcare (Drug Manufacturers - General), listed on NASDAQ, US.
Is CTOR in an uptrend or downtrend?
As of 2026-09-11, CTOR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CTOR's trailing P/E ratio?
CTOR's trailing P/E is -1.22, with a market cap of 0.06B. See the earnings research page for full valuation detail.
When does CTOR next report earnings?
CTOR is next scheduled to report earnings on 2026-08-18, with a consensus EPS estimate of -0.04 USD.